Elicio Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors (NCT05726864) | Elicio Therapeutics | 2023-04-14 |
| A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (NCT04853017) | Elicio Therapeutics | 2021-10-04 |
Track Elicio Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.